SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ·Healthcare·Biotechnology
$4.84
-0.76%
Mkt Cap $660.93M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | — | — | — | -$0.06 | -$0.05 | +21.05% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.06 | -$0.06 | +5.26% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.08 | -$0.07 | +16.00% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.10 | -$0.07 | +30.00% | — | — |
| Q1 2025 Mar 20, 2025 | — | — | — | -$0.11 | -$0.08 | +27.27% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.13 | -$0.10 | +23.08% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.16 | -$0.13 | +18.75% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.16 | -$0.21 | -31.25% | — | — |
| Q1 2024 Mar 28, 2024 | $13.00M | — | — | $0.09 | -$0.25 | -388.45% | — | — |
| Q4 2023 Nov 9, 2023 | $13.00M | — | — | -$0.03 | -$0.33 | -1200.24% | — | — |
| Q3 2023 Aug 10, 2023 | $6.50M | — | — | -$0.35 | -$0.31 | +11.43% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.29 | -$0.47 | -62.07% | — | — |
| Q1 2023 Mar 16, 2023 | — | $1.00M | — | $0.32 | -$0.43 | -234.38% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.39 | -$0.34 | +12.82% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.35 | -$0.41 | -17.14% | — | — |
| Q2 2022 May 12, 2022 | $1.00M | $1.00M | +0.00% | -$0.38 | -$1.05 | -176.32% | — | — |
| Q1 2022 Mar 31, 2022 | — | $7.60M | — | -$0.40 | -$0.42 | -4.13% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | -$0.38 | -$0.45 | -18.42% | — | — |
| Q3 2021 Aug 12, 2021 | $1.90M | $1.90M | +0.00% | -$0.39 | -$0.30 | +23.08% | — | — |
| Q2 2021 May 13, 2021 | $7.22M | $5.70M | -21.05% | -$0.27 | -$0.16 | +40.74% | — | — |